This research study is studying a combination of targeted therapy and hormonal therapy as a
possible treatment for breast cancer that has spread to other places in the body and is
hormone receptor positive (HR+) and HER2-negative.
The names of the study interventions involved in this study are:
- Palbociclib
- Everolimus
- Exemestane